• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者疾病进展指标与总费用的相关性。

Association between illness progression measures and total cost in Alzheimer's disease.

机构信息

Loretto Lacey PhD, Lacey Solutions, Dublin Ireland. Email:

出版信息

J Nutr Health Aging. 2013 Sep;17(9):745-50. doi: 10.1007/s12603-013-0368-1.

DOI:10.1007/s12603-013-0368-1
PMID:24154646
Abstract

OBJECTIVE

To compare the associations between dependence and clinical measures of cognition, function and behaviour and total care cost using data from a longitudinal study in Alzheimer's disease (AD).

DESIGN

Longitudinal, observational study.

SETTING

Community-dwelling subjects.

PARTICIPANTS

Male and female subjects between 50 and 85 years of age with mild to moderate AD.

INTERVENTION

None.

MEASUREMENTS

Subject dependence was assessed using the Dependence Scale (DS), cognition (ADAS-Cog, MMSE), function (DAD), behaviour (NPI) and resource utilization with the Resource Utilization in Dementia Questionnaire.

RESULTS

The repeated measures models confirmed a significant association between the DS and total care cost indicating an increase in cost with increasing dependence. A 1-unit increase in DS score was associated with a 28.60% increase in total care cost. Model 2 indicated that a one point change in MMSE, DAD and NPI is associated with 5.29%, 2.32% and 1.71% increase in total cost, respectively. Model 3 indicated that a one point change in ADAS-Cog, DAD and NPI is associated with a 1.74%, 2.42%and 1.62% increase in total cost, respectively.

CONCLUSION

Strategies which prevent deterioration in clinical measures or delay dependence should result in total cost savings. The quantitative relationships observed should assist in the economic assessment of interventions which effect cognition, function, behaviour and dependence.

摘要

目的

利用来自阿尔茨海默病(AD)纵向研究的数据,比较依赖与认知、功能和行为的临床指标以及总护理费用之间的关系。

设计

纵向观察性研究。

地点

居住在社区的受试者。

参与者

年龄在 50 至 85 岁之间,轻度至中度 AD 的男性和女性受试者。

干预措施

无。

测量

使用依赖量表(DS)、认知(ADAS-Cog、MMSE)、功能(DAD)、行为(NPI)和资源利用量表(Resource Utilization in Dementia Questionnaire)评估受试者的依赖程度。

结果

重复测量模型证实了 DS 与总护理费用之间存在显著关联,表明依赖程度增加与费用增加相关。DS 评分增加 1 个单位,总护理费用增加 28.60%。模型 2 表明,MMSE、DAD 和 NPI 每变化 1 点,总费用分别增加 5.29%、2.32%和 1.71%。模型 3 表明,ADAS-Cog、DAD 和 NPI 每变化 1 点,总费用分别增加 1.74%、2.42%和 1.62%。

结论

预防临床指标恶化或延缓依赖的策略应导致总费用节省。观察到的定量关系应有助于对影响认知、功能、行为和依赖的干预措施进行经济评估。

相似文献

1
Association between illness progression measures and total cost in Alzheimer's disease.阿尔茨海默病患者疾病进展指标与总费用的相关性。
J Nutr Health Aging. 2013 Sep;17(9):745-50. doi: 10.1007/s12603-013-0368-1.
2
Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.阿尔茨海默病连续体中的依赖程度作为临时临床里程碑:来自 GERAS 观察性研究的 18 个月结果。
J Prev Alzheimers Dis. 2017;4(2):72-80. doi: 10.14283/jpad.2017.2.
3
Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.与阿尔茨海默病痴呆进展过程中对非正式照护者的长期影响相关的因素:来自 GERAS 的 36 个月结果。
Int Psychogeriatr. 2020 Feb;32(2):267-277. doi: 10.1017/S1041610219000425. Epub 2019 May 28.
4
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.在轻度至中度阿尔茨海默病(AD)的治疗中,阿托伐他汀疗法可降低循环胆固醇,但在出现可识别的临床益处之前,并不会降低自由基活性。
Curr Alzheimer Res. 2005 Jul;2(3):343-53. doi: 10.2174/1567205054367900.
5
The effects of patient function and dependence on costs of care in Alzheimer's disease.阿尔茨海默病患者功能及依赖程度对护理成本的影响。
J Am Geriatr Soc. 2008 Aug;56(8):1497-503. doi: 10.1111/j.1532-5415.2008.01798.x. Epub 2008 Jul 24.
6
Bridging from clinical endpoints to estimates of treatment value for external decision makers.从临床终点到为外部决策者评估治疗价值的桥梁搭建。
J Nutr Health Aging. 2009 Mar;13(3):256-9. doi: 10.1007/s12603-009-0068-z.
7
Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.日本社区居住的阿尔茨海默病患者的成本和资源利用:前瞻性观察 GERAS-J 研究的基线结果。
J Alzheimers Dis. 2020;74(1):127-138. doi: 10.3233/JAD-190811.
8
Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.意大利阿尔茨海默病的成本和资源利用:一项观察性研究的结果。
J Prev Alzheimers Dis. 2018;5(1):55-64. doi: 10.14283/jpad.2017.31.
9
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.阿尔茨海默病轻度与中度阶段:胆碱酯酶抑制剂治疗常规临床环境中的三年结局
Alzheimers Res Ther. 2016 Feb 17;8:7. doi: 10.1186/s13195-016-0174-1.
10
Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease.阿尔茨海默病患者疾病指标对非正规护理和照顾者负担的相对重要性。
Int Psychogeriatr. 2011 Feb;23(1):73-85. doi: 10.1017/S1041610210000785. Epub 2010 Jul 12.

引用本文的文献

1
Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.评估阿尔茨海默病经济负担的主要成本驱动因素:一项结构化、快速审查。
J Prev Alzheimers Dis. 2021;8(3):362-370. doi: 10.14283/jpad.2021.17.
2
Cost of care for persons with dementia: using a discrete-time Markov chain approach with administrative and clinical data from the dementia service Centres in Austria.痴呆症患者的护理成本:采用离散时间马尔可夫链方法,结合来自奥地利痴呆症服务中心的行政和临床数据。
Health Econ Rev. 2020 Sep 14;10(1):29. doi: 10.1186/s13561-020-00285-w.
3
Acute Healthcare Utilization of a Multidisciplinary Neurocognitive Dementia Patient Cohort.

本文引用的文献

1
Exploring the relationship between Alzheimer's disease severity and longitudinal costs.探讨阿尔茨海默病严重程度与纵向成本之间的关系。
Value Health. 2012 May;15(3):412-9. doi: 10.1016/j.jval.2012.02.003. Epub 2012 Apr 10.
2
Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.轻度至中度阿尔茨海默病临床试验样本中的护理成本:关键资源及其决定因素。
Alzheimers Dement. 2011 Jul;7(4):466-73. doi: 10.1016/j.jalz.2010.06.002.
3
Dependence as a unifying construct in defining Alzheimer's disease severity.
多学科神经认知痴呆患者队列的急性医疗利用情况
J Clin Neurol. 2020 Jul;16(3):433-437. doi: 10.3988/jcn.2020.16.3.433.
4
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes.一项为期18个月的观察性研究(GERAS):阿尔茨海默病所致轻度痴呆的疾病进展对成本和照料者结局的影响
Dement Geriatr Cogn Dis Extra. 2017 Mar 20;7(1):87-100. doi: 10.1159/000461577. eCollection 2017 Jan-Apr.
5
Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.阿尔茨海默病患者的依赖阶段与药物经济学结果
Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):209-217. doi: 10.1097/WAD.0000000000000198.
6
Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes-The insideDEM framework.养老院中痴呆晚期挑战性行为的多维评估——insideDEM框架
Alzheimers Dement (Amst). 2017 Apr 4;8:36-44. doi: 10.1016/j.dadm.2017.03.006. eCollection 2017.
7
Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.患有阿尔茨海默病且至少接受过一次手术的住院患者医疗资源使用的趋势、预测因素及结果:全国住院患者样本
J Alzheimers Dis. 2017;57(3):813-824. doi: 10.3233/JAD-161225.
8
Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression Study.照护者与受照护者之间更亲密的关系预示着痴呆症照护的非正式成本更低:卡什县痴呆症进展研究。
Alzheimers Dement. 2016 Aug;12(8):917-24. doi: 10.1016/j.jalz.2016.03.008. Epub 2016 Apr 18.
9
Dementia severity and the longitudinal costs of informal care in the Cache County population.卡什县人群中的痴呆严重程度与非正式护理的纵向成本
Alzheimers Dement. 2015 Aug;11(8):946-54. doi: 10.1016/j.jalz.2014.11.004. Epub 2015 Jan 19.
将依赖作为定义阿尔茨海默病严重程度的统一结构。
Alzheimers Dement. 2010 Nov;6(6):482-93. doi: 10.1016/j.jalz.2009.09.004.
4
Alzheimer's disease: the strength of association of costs with different measures of disease severity.阿尔茨海默病:成本与不同疾病严重程度衡量指标之间关联的强度。
J Nutr Health Aging. 2010 Oct;14(8):655-63. doi: 10.1007/s12603-010-0312-6.
5
Assessment of potential measures in models of progression in Alzheimer disease.阿尔茨海默病进展模型中潜在措施的评估。
Neurology. 2010 Oct 5;75(14):1256-62. doi: 10.1212/WNL.0b013e3181f6133d.
6
Patient dependence and longitudinal changes in costs of care in Alzheimer's disease.阿尔茨海默病患者的依赖性及护理成本的纵向变化
Dement Geriatr Cogn Disord. 2008;26(5):416-23. doi: 10.1159/000164797. Epub 2008 Oct 22.
7
The effects of patient function and dependence on costs of care in Alzheimer's disease.阿尔茨海默病患者功能及依赖程度对护理成本的影响。
J Am Geriatr Soc. 2008 Aug;56(8):1497-503. doi: 10.1111/j.1532-5415.2008.01798.x. Epub 2008 Jul 24.
8
Evaluated need, costs of care, and payer perspective in degenerative dementia patients cared for in the United States.美国退行性痴呆患者的评估需求、护理成本及支付方视角
Alzheimer Dis Assoc Disord. 2007 Jan-Mar;21(1):39-48. doi: 10.1097/WAD.0b013e31802f2426.
9
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.阿尔茨海默病患者特征对直接成本影响的纵向研究。
Neurology. 2006 Sep 26;67(6):998-1005. doi: 10.1212/01.wnl.0000230160.13272.1b. Epub 2006 Aug 16.
10
Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument.时间评估的有效性和可靠性。使用痴呆症资源利用(RUD)工具对直接观察和时间估计进行比较。
Arch Gerontol Geriatr. 2007 Jan-Feb;44(1):71-81. doi: 10.1016/j.archger.2006.03.001. Epub 2006 Jun 13.